skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Folate Binding Protein E39 Peptide Vaccine (Code C101530)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Folate Binding Protein E39 Peptide Vaccine

Definition: A cancer vaccine comprised of human leukocyte antigen (HLA) A2 restricted folate binding protein (FBP) epitope E39 (amino acids 191 to 199), with potential immunostimulatory and antineoplastic activity. Upon intradermal injection, FBP E39 peptide vaccine may induce a specific cytotoxic T-lymphocyte (CTL) response against FBP-expressing tumor cell types. FBP is a membrane-bound, tumor-associated antigen highly overexpressed in various tumor cell types, such as in breast, ovarian and endometrial cancers; E 39 is a strong immunogenic peptide.

Label: Folate Binding Protein E39 Peptide Vaccine

NCI Thesaurus Code: C101530 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL435783  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
E39 Peptide Vaccine
FBP E39 Peptide Vaccine
Folate Binding Protein E39 Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 732482
PDQ Open Trial Search ID 732482 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C101530
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom